Lepu Biopharma Co., Ltd. (HKG:2157)

Hong Kong · Delayed Price · Currency is HKD

9.76

-0.19 (-1.91%)

Aug 15, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Pharmaceutical Products	325.63M	Log In	Log In
Pharmaceutical Products Growth	190.66%	Log In	Log In
Contract Development and Manufacturing Organisations Services	49.33M	Log In	Log In
Licensing Income	23.81M	Log In	Log In
Licensing Income Growth	-82.62%	Log In	Log In
Drugs for Cancer Targeted Therapy and Immunotherapy	-	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
China	374.96M	Log In	Log In
China Growth	234.69%	Log In	Log In
Overseas	23.81M	Log In	Log In
Overseas Growth	-82.62%	Log In	Log In